Additionally, the expression subtypes of FLOT1 (FLOT1 high and low), as determined by the average score, did not significantly predict the prognosis of HNSCC (43.2% vs. 49.9% at 5 years, P = 0.161; Supplementary Fig. 1). This evidence concerns the gene FLOT1 and head and neck squamous cell carcinoma.